We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.75 | 9.50 | 10.00 | 9.75 | 9.75 | 9.75 | 10,208 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0163 | -5.98 | 16.97M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/11/2017 10:35 | It is far better in my view for PI's to invest in OPTI because their future potential is enormous and PI's will benefit from future spin-offs. :) | loungeact | |
23/11/2017 10:00 | It is far better in my view for PI's to invest in the spin off businesses because there future potential is enormous as they get unhitched from OPTI. | bobalot | |
23/11/2017 09:35 | Then show us where elrico said sbtx is a sub of opti. He said it WAS not is. Now you are resorting to lies. | incanus | |
23/11/2017 09:29 | Bobby, you forgot to Start with a capital letter there. Just saying.. | loungeact | |
23/11/2017 09:15 | HE SAID IT WAS A SUBSIDIARY MANY TIMES.... The qualifying shareholding for a parent company is a 50% shareholding...OPTI have 41% of SBTX and are planning to give some of that away to OPTI LTH's. | bobalot | |
23/11/2017 06:00 | MY not be a subsidiary but 40+% is usually a controlling holding. All just my uninformed opinion. | aspex | |
23/11/2017 04:28 | Take another look at the email I got from SBTX and tell Elrico he is completely wrong in his analysis; people like myself deserve an apology. Thank you for your mail which Cath forwarded on. Your understanding is correct, Opti own 41% of the shares in SBTX which is below the 50% level required to be deemed a subsidiary. Technically Opti’s investment in SBTX is defined as an ‘associate undertaking’ and it carries its holding in SBTX as an investment on its balance sheet. From a practical point of view Opti & SBTX are two separate and independent companies with separate management teams and boards. As you are probably aware, Stephen O’Hara (CEO of Opti) sits on the board of SBTX as an NED. All other directors at SBTX are independent of and have no involvement with Opti. What Opti may or may not do with its holding in SBTX in the future is not something we’re in a position to comment on. I hope this is of some assistance. Kind regards Doug Quinn | bobalot | |
23/11/2017 04:26 | slartybartfaster 22 Nov '17 - 19:33 - 913 of 915 4 0 (Filtered) Read what Elrico has been saying about SBTX being a subsidiary...so get your facts straight. If OPTI don't develop more early stage divisions from University projects it will become a cash shell holding just stock in its four divisions. They are not going to be subsidiaries, unless there is a change of plan. With SkinBio, OPTI have zero leverage and are merely influencers on the BoD without any legal rights. If the other proposed divisions follow the same model then OPTI becomes an investment entity that can be cashed out at any time. It would be a more convincing model if the pipeline of projects was growing but it looks more like the current projects are the only projects. It is, in my view, better for PI's to invest in the spun out businesses. Because each time a division is off loaded onto the market OPTI actually losses about 60% of its inherent value. | bobalot | |
23/11/2017 04:16 | You will be humbled if OPTI becomes an equivalent CASH SHELL once the four divisions have been spun out leaving the company with a stock pile of shares that can be cashed out at any time. DYOR I LIVE IN A DIFFERENT TIME ZONE SO THIS MAY LOOK LIKE AN EARLY MORNING CALL FOR BRITS. | bobalot | |
22/11/2017 22:28 | All i know is bobalot is going to look very humble when we get our sbtx shares for nothing. Will he have the courage to apologise? | pglancy | |
22/11/2017 19:33 | So much for having me filtered. Anyway, back on point and back to school for you bob. Correcting your facts first opti own 49,794,190 - 41.9% not 44 million as you state. The debt was actually a convertible loan note in which opti used to retain OptiBiotix Health Plc 49,794,190 - 41.9%. Nobody suggested sbtx was or is a sub of opti. If they did provide the proof. | slartybartfaster | |
22/11/2017 19:25 | slartybartfaster 2 Nov '17 - 19:21 - 911 of 911 0 0 (Filtered) TRY EDUCATING YOURSELF BETTER imo. The monies used to develop SkinBio and it's research by OPTI was accounted for as a debt and then exchanged for shares amounting to about 44 million in total....same as a debt for equity swap. READ THE RNS's | bobalot | |
22/11/2017 19:21 | Opti did not sell off sbtx and what debt debt? Opti spun out an investment and retain a majority holding from what WAS A SUB of Opti. You need to sort your facts out coz until you do nobody can take you seriously. | slartybartfaster | |
22/11/2017 19:16 | Nobody said sbtx was a sub of opti, elrico was talking in past tense. Everyone knows sbtx is now independent of opti and opti remain the largest shareholder. FFS ITS NOT ROCKET SCIENCE. Pestering a ceo for such trivial nonsense is embarrassing. By the way opti own 41.9% not 41%. | slartybartfaster | |
22/11/2017 19:10 | Bob, you're not making many friends for the long haul. The funny thing is we're all on the same side, that is we're all invested in SBTX and want it to do fabulously well. I Suggest you burry the hatchet and let's start acting like grown up's so that we can use this thread for its purpose, research and ideas sharing - rather than name calling? | trotterstrading | |
22/11/2017 18:44 | I knew I was right so some apologies are in order from the OPTI evangelists. IN CASE SOME DON'T KNOW AHAT A ned IS HERE IS THE ANSWER: SOH IS A NED FOR SBTX AND it carries no authority from a legal standpoint. A non-executive director (abbreviated to non-exec, NED or NXD) or external director is a member of the board of directors of a company or organisation who does not form part of the executive management team. They are not employees of the company or affiliated with it in any other way and are differentiated from inside directors, who are members of the board who also serve or previously served as executive managers of the company (most often as corporate officers). However they do have the same legal duties, responsibilities and potential liabilities as their executive counterparts. Non-executive directors are directors who act in advisory capacity only. Typically, they attend monthly board meetings to offer the benefit of their advice and serve on committees concerned with sensitive issues such as the pay of the executive directors and other senior managers; they are usually paid a fee for their services but are not regarded as employees. All directors should be capable of seeing company and business issues in a broad perspective. Nonetheless, non-executive directors are usually chosen because of their independence and initiatives, and are of an appropriate caliber and have particular personal qualities. | bobalot | |
22/11/2017 18:36 | elrico 22 Nov '17 - 17:56 - 04 of 905 0 0 has some egg on his face....SBTX IS NOT A SUBSIDIARY...SUCK ON THAT. so giving away free stock will need some legal hurdles to be overcome....not the established mechanism you have been touting imo....lol@Elrico | bobalot | |
22/11/2017 18:34 | HERE IS THE DEFNITIVE ANSWER to the relationship between OPTI and SBTX...so I hope the muppets from OPTI get this between their ears and stop whinging. Thank you for your mail which Cath forwarded on. Your understanding is correct, Opti own 41% of the shares in SBTX which is below the 50% level required to be deemed a subsidiary. Technically Opti’s investment in SBTX is defined as an ‘associate undertaking’ and it carries its holding in SBTX as an investment on its balance sheet. From a practical point of view Opti & SBTX are two separate and independent companies with separate management teams and boards. As you are probably aware, Stephen O’Hara (CEO of Opti) sits on the board of SBTX as an NED. All other directors at SBTX are independent of and have no involvement with Opti. What Opti may or may not do with its holding in SBTX in the future is not something we’re in a position to comment on. I hope this is of some assistance. Kind regards Doug Quinn | bobalot | |
22/11/2017 17:56 | It's not fun attempting to assists someone that refuses to see the bleeding obvious, no matter how many ways attempts are made to explain. Bobalot is obviously one of those peeps that right even when he is wrong....there is not helping those types, so I have resorted to the filter for the sake of my own sanity. | elrico | |
22/11/2017 16:59 | Elrico looks like you had fun today!! Suggest someone looks up the word bigoted while they have the dictionary out... | 1bokke |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions